中文

Cencora, Inc. Revenue Breakdown

Period 2026-03-31 (quarterly) ・ Reported 2026-05-06
ItemAmountY/Y
Revenue$78.36B+3.8%
Gross profit$3.59B
Operating income$1.14B
Net income$1.64B+128.6%
Gross margin4.6%Net margin 2.1%
Revenue Q/Q-8.8%

Revenue Segments

SegmentRevenueShare
USHealthcare Solutions$68.77B87.8%
International Healthcare Solutions$7.57B9.7%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$74.77B95.4%
SG&A$1.98B2.5%
Tax & other$-0.50B-0.6%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

CNCCNPCFCRLSCHWCHTRCVXCMGCBCHDCIENCI

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies